Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

NCT07475403
Recruiting
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · China · 3 sites
Registry update: 26 May 2026
NCT07475806
Recruiting
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Phase 2 · Australia, Canada, China, Germany, Spain, France, United Kingdom, Italy, Japan, South Korea, Poland, United States · 68 sites
Registry update: 2 Nov 2026
NCT07421700
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/2 · Australia, China, Spain, Japan, Puerto Rico, United States · 179 sites
Registry update: 8 Oct 2026
NCT07302230
Recruiting
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Not applicable · United States · 1 site
Registry update: 6 Jul 2026
NCT06822010
Recruiting
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Phase 2 · United States · 1 site
Registry update: 6 May 2026
NCT07043543
Recruiting
Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)
Not applicable · France · 11 sites
Registry update: 9 Nov 2026
NCT07277413
Recruiting
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · United States · 23 sites
Registry update: 28 Sept 2026
NCT07492628
Recruiting
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
Phase 1 · China · 1 site
Registry update: 25 Mar 2026
NCT07514897
Recruiting
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Not applicable · China · 1 site
Registry update: 7 Apr 2026
NCT07441499
Recruiting
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Not applicable · China · 1 site
Registry update: 2 Mar 2026
NCT07474519
Recruiting
Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer
Phase 4 · United States · 1 site
Registry update: 16 Mar 2026
NCT07424560
Recruiting
Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
Not applicable · China · 1 site
Registry update: 24 Feb 2026
NCT07413523
Recruiting
Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA
Not applicable · Italy · 1 site
Registry update: 30 Apr 2026
NCT07337525
Recruiting
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Phase 1 · United States · 4 sites
Registry update: 7 Jul 2026
NCT07393542
Recruiting
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
Phase 3 · China · 1 site
Registry update: 14 Aug 2026
NCT07059884
Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
Not applicable · United States · 30 sites
Registry update: 4 Nov 2026
NCT07232602
Recruiting
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Phase 1/2 · Chile, Spain, France, United Kingdom, Israel, South Korea, Netherlands, United States · 17 sites
Registry update: 2 Oct 2026
NCT07227077
Recruiting
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Not applicable · United States · 1 site
Registry update: 20 Aug 2026
NCT07287995
Recruiting
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Phase 1/2 · Japan, United States · 9 sites
Registry update: 22 Oct 2026
NCT06447064
Recruiting
Cancer Loyalty Card Study 2 (CLOCS-2)
Not applicable · United Kingdom · 1 site
Registry update: 25 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.